Yu-Chuan LU

Full Name
Yu-Chuan LU
Nationality
Taiwan
Position
Assistant Professor
Organization
National Taiwan University Cancer Center
Brief Bio
Dr. Yu-Chuan Lu is an Assistant Professor in the Department of Urology at the National Taiwan University College of Medicine, with nine years of experience in minimally invasive urological oncology operations. Dr. Lu specializes in robotic and laparoscopic urological surgery, as well as urological oncology. He has received the Taiwan Urological Robotic and Laparoscopic Surgery Video Award three times (in 2019, 2021, and 2023). Additionally, he is a clinical researcher whose studies are focused on the relationship between urological cancers and natural killer cell activity.
Specialty
 Urological Surgery  Urological Oncology
Education
 Ph.D. Institute of Biomedical Engineering, National Taiwan University  Medical Doctor, Medical School at the National Taiwan University
Honors/Awards
 The second Taiwan Urological Robotic and Laparoscopic Surgery Video Award, 2019  The Fourth Taiwan Urological Robotic and Laparoscopic Surgery Video Award, 2021  The 6th Taiwan Urological Robotic and Laparoscopic Surgery Video Award, 2023
Publication
 Lu YC, Ho CH, Hong JH, Kuo MC, Liao YA, Jaw FS, Cheng JC, Huang CY, Chang KP, Chen CH, Lin JA, Hsiao A, Kung HN: NKG2A and circulating extracellular vesicles are key regulators of natural killer cell activity in prostate cancer after prostatectomy. Mol Oncol. 2023 Aug;17(8):1613-1627. doi: 10.1002/1878-0261.13422. Epub 2023 Mar 27.  Yu-Chuan Lu, Ming-Chieh Kuo, Jian-Hua Hong, Fu-Shan Jaw, Chao-Yuan Huang, Jason Chia‐Hsien Cheng, Hsiu-Ni Kung. Lower postoperative natural killer cell activity is associated with positive surgical margins after radical prostatectomy. J Formos Med Assoc. 2020 Feb 17. pii: S0929-6646(20)30001-2  Yu-Chuan Lu, Chao-Yuan Huang, Huei-Ming Yeh, Jian-Hua Hong, Chao-Hsiang Chang, Chih-Hsin Muo, Shiu-Dong Chung, Teng-Kai Yang, Fu-Shan Jaw, Chi-Jung Chung. Associations between peripheral thromboembolic Vascular Disease and Androgen Deprivation therapy in Asian prostate cancer patients. Sci Rep. 2019 Oct 2;9(1):14231. doi: 10.1038/s41598-019-50522-4.